Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)

NCT05090280 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: PF614 solution
DRUG: Naltrexone Hydrochloride
DRUG: Nafamostat Mesylate

Sponsor

Ensysce Biosciences

Collaborators

[object Object]
[object Object]